Cell lines from MYCN transgenic murine turnours reflect the molecular and biological characteristics of human neuroblastorna

被引:32
作者
Cheng, Andy J.
Cheng, Ngan Ching
Ford, Jette
Smith, Janice
Murray, Jayne E.
Flemming, Claudia
Lastowska, Maria
Jackson, Michael S.
Hackett, Christopher S.
Weiss, William A.
Marshall, Glenn M.
Kees, Ursula R.
Norris, Murray D.
Haber, Michelle
机构
[1] Childrens Canc Inst Australia Med Res, Randwick, NSW 2031, Australia
[2] Telethon Inst Child Hlth Res, Perth, WA, Australia
[3] Univ Newcastle Upon Tyne, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[4] Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA
关键词
neuroblastoma; MYCN oncogene; transgenic mice; murine cell lines;
D O I
10.1016/j.ejca.2007.03.008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Overexpression. of the human MYCN oncogene driven by a tyrosine hydroxylase promoter causes tumours in transgenic mice that recapitulate the childhood cancer neuroblastoma. To establish an in vitro model to study this process, a series of isogenic cell lines were developed from these MYCN-driven murine tumours. Lines were established from tumours arising in homozygous and hemizygous MYCN transgenic mice. Hemizygous tumours gave rise to cell lines growing only in suspension. Homozygous tumours gave rise to similar suspension lines as well as morphologically distinct substrate-adherent lines characteristic of human S-type neuroblastoma cells. FISH analysis demonstrated selective MYCN transgene amplification in cell lines derived from hemizygous mice. Comparative genomic hybridisation (CGH) and fluorescence in situ hybridisation (FISH) analysis confirmed a range of neuroblastoma-associated genetic changes in the various lines, in particular, gain of regions syntenic with human 17q. These isogenic lines together with the transgenic mice thus represent valuable models for investigating the biological characteristics of aggressive neuroblastoma. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1467 / 1475
页数:9
相关论文
共 25 条
[1]   ORNITHINE DECARBOXYLASE ACTIVITY IS CRITICAL FOR CELL-TRANSFORMATION [J].
AUVINEN, M ;
PAASINEN, A ;
ANDERSSON, LC ;
HOLTTA, E .
NATURE, 1992, 360 (6402) :355-358
[2]   Involvement of Myc targets in c-myc and N-myc induced human tumors [J].
Ben-Yosef, T ;
Yanuka, O ;
Halle, D ;
Benvenisty, N .
ONCOGENE, 1998, 17 (02) :165-171
[3]  
BORDOW SB, 1994, CANCER RES, V54, P5036
[4]   Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma [J].
Bown, N ;
Cotterill, S ;
Lastowska, M ;
O'Neill, S ;
Pearson, ADJ ;
Plantaz, D ;
Meddeb, M ;
Danglot, G ;
Brinkschmidt, C ;
Christiansen, H ;
Laureys, G ;
Speleman, F .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (25) :1954-1961
[5]   AMPLIFICATION OF N-MYC IN UNTREATED HUMAN NEUROBLASTOMAS CORRELATES WITH ADVANCED DISEASE STAGE [J].
BRODEUR, GM ;
SEEGER, RC ;
SCHWAB, M ;
VARMUS, HE ;
BISHOP, JM .
SCIENCE, 1984, 224 (4653) :1121-1124
[6]   Neuroblastoma: Biological insights into a clinical enigma [J].
Brodeur, GM .
NATURE REVIEWS CANCER, 2003, 3 (03) :203-216
[7]   Effects of MYCN antisense oligonucleotide administration on tumorigenesis in a murine model of neuroblastoma [J].
Burkhart, CA ;
Cheng, AJ ;
Madafiglio, J ;
Kavallaris, M ;
Mili, M ;
Marshall, GM ;
Weiss, WA ;
Khachigian, LM ;
Norris, MD ;
Haber, M .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (18) :1394-1403
[8]  
CICCARONE V, 1989, CANCER RES, V49, P219
[9]  
GERAN RI, 1972, CANCER CHEMOTHERAP 3, V3, P47
[10]   Altered expression of the MYCN oncogene modulates MRP gene expression and response to cytotoxic drugs in neuroblastoma cells [J].
Haber, M ;
Bordow, SB ;
Gilbert, J ;
Madafiglio, J ;
Kavallaris, M ;
Marshall, GM ;
Mechetner, EB ;
Fruehauf, JP ;
Tee, L ;
Cohn, SL ;
Salwen, H ;
Schmidt, ML ;
Norris, MD .
ONCOGENE, 1999, 18 (17) :2777-2782